NCT00082914 2013-06-20Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney CancerNational Cancer Institute (NCI)Phase 2 Completed
NCT00278369 2013-05-22Pilot Study of Denileukin Diftitox Plus High-Dose IL-2 for Patients With Metastatic Renal CancerNorthwestern UniversityPhase EARLY_PHASE1 Completed20 enrolled